Ambulatory Blood Pressure Monitoring Market Overview
Ambulatory Blood Pressure Monitoring Market size is estimated to reach $1.7 billion by 2027, growing at a CAGR of 6.9% during the forecast period 2022-2027. Ambulatory blood pressure monitoring is delineated as a process of measuring blood pressure on a daily basis over a 24-hour time span. Generally, arm and wrist monitors are attached to the body which takes all necessary readings while the body moves. It also helps in precise monitoring and reducing the white coat hypertension (WHT) as many people suffer from a condition known as white coat syndrome in which blood pressure reading changes at the drop of a hat the second, they visit the doctor’s office, this abnormality can put them at risk of severe medical conditions if not diagnosed and treated timely. ABPM’s ability to distinguish atypical vicissitudes in blood pressure significantly enlarges people’s consciousness regarding nocturnal hypertension which is commonly associated with cerebrovascular and cardiovascular disease (CVD). The Ambulatory Blood Pressure Monitoring Market outlook is fairly appealing as the prevalence of hypertension has come to the foreground on an unprecedented scale in recent years. Also. accruing health awareness among people and augmenting incidences of heart attacks are factors set to drive the growth of the Ambulatory Blood Pressure Monitoring Market for the period 2022-2027.
The report: “Ambulatory Blood Pressure Monitoring Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Ambulatory Blood Pressure Monitoring Market.
Type: Upper Arm and Wrist Monitors.
By End User: Ambulatory surgical centers ASCs, Hospitals, Clinics, and Households.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).
- Geographically, the North America Ambulatory Blood Pressure Monitoring Market accounted for the highest revenue share in 2021. However, Asia-Pacific is poised to dominate the market over the period 2022-2027.
- Expanding the elderly population and technological breakthroughs in the development of contemporary devices for measuring blood pressure is said to be a preeminent driver driving the growth of the Ambulatory Blood Pressure Monitoring Market. Unawareness of a major faction regarding the existence of such devices is said to reduce the market growth.
- Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Ambulatory Blood Pressure Monitoring Market report.
Ambulatory Blood Pressure Monitoring Market Share, By Geography (%) in 2021
For More Details on This Report - Request for Sample
Ambulatory Blood Pressure Monitoring Market Segment Analysis-By Product Type
The Ambulatory Blood Pressure Monitoring Market based on the product type can be further segmented into arm and wrist monitors. The wrist monitors segment held the largest share in 2021. The growth is owing to higher convenience as compared to arm monitors. Wrist monitors can be used as watches because they are lightweight compared to upper arm monitors due to their compact and slick design. Therefore, they extend better portability. Moreover, due to their digital screen, they are easy to use and keep a track of blood pressure on a daily basis. Upper arm monitors are a good alternative because they are considered to be of a slightly more precise nature but their complex process and unportable nature are what turn people away from them. Similarly, the wrist monitor segment is estimated to be the fastest-growing segment with a CAGR of 7.8% over the forecast period 2022-2027. This growth is owing to accuracy in the dissemination of readings. Therefore, their popularity is elevating among working professionals owing to their portability and on-the-spot reading. Besides, wrist monitors are capable of storing the previous readings which may help in tracking the progress by comparing them with newer readings.
Ambulatory Blood Pressure Monitoring Market Segment Analysis-By End User
The Ambulatory Blood Pressure Monitoring Market based on end-user can be further segmented into ambulatory surgical centers ASCs, hospitals, clinics, retail medical stores, and households. The hospital segment held the largest share in 2021. The growth is owing to intensification in hypertension due to higher stress levels as the entire world was in lockdown. Usually, maximum people go to a hospital for a regular checkup as hospitals are the first point of contact for them. Moreover, complex medical terms which people cannot comprehend without doctors are another reason behind the growth in the respective segment. However, the household segment is estimated to be the fastest-growing segment with a CAGR of 8.3% over the forecast period 2022-2027. This growth is owing to the rising demand for contemporary monitoring devices such as arm and wrist monitors. Due to their digital nature, these devices can be used easily without the assistance of any medical practitioner. On another hand, the wide-scale prevalence of cardiovascular illnesses due to abnormal blood pressure has played a significant role in augmenting health awareness among people. Therefore, in order to keep a track of their blood pressure, people are opting for these modern devices.
Ambulatory Blood Pressure Monitoring Market Segment Analysis-By Geography
The Ambulatory Blood Pressure Monitoring Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 39% of the overall market in 2021. The growth in this segment is owing to the factors such as higher health consciousness among people compared to other parts of the world. Moreover, the obesity prevalence in the U.S. is more common which is another reason behind soaring hypertension cases because an obese person experiences higher deposition of adipose tissue which sets many cascades of events in motion and eventually raises blood pressure. However, Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to accruing prevalence of old-age residents which is the major reason behind the upsurge of cardiovascular diseases. On another hand, with prospering economies, the purchasing capacity and living standards of people have heightened over the years which is another factor fueling the growth in the Ambulatory Blood Pressure Monitoring Market.
Ambulatory Blood Pressure Monitoring Market Drivers
Augmenting cardiovascular hitches due to hypertension is Anticipated to Boost Product Demand
Attributing to the broadening trend of stress and worries in modern-day society hypertension has emerged as a prime by-product on an unprecedented scale. According to a WHO study, every year hypertension disturbs over 28-30% of adults around the globe. For instance, in 2021 around 16 million that is 47% of American adults were facing systolic blood pressure (SBP) over 130mmHg. This colossal upsurge is a prominent reason behind growing cardiovascular complications worldwide. A report claims that around 50% of strokes and heart attacks ascribe to high blood pressure.
Proliferating health consciousness is Expected to Boost Product Demand
Rising health awareness among people is a major driver of the Ambulatory Blood Pressure Monitoring Market. But, “What is the reason behind this awareness?” Rapid modernization is encouraging people to forsake the countryside and migrate to cities. As a result of which, more than 50% of that is around 4.46 billion residing in urban areas and by 2050 the respective figure is estimated to reach 6.68 billion. People living in cities enjoy better living standards and uphold higher awareness than those residing in pastoral areas. Therefore, in order to live a healthy life demands for blood pressure monitoring devices, health devices, and gym memberships are heightening.
Ambulatory Blood Pressure Monitoring Market Challenges
Unawareness regarding the existence of such devices and widescale unemployment attributed to the COVID-19 are Anticipated to Hamper Market Growth
There is no doubt about it that the overall health alertness of people is stimulating which can drive the demand n the respective market but still, a major faction of the population living in impoverished is unaware of the existence of such devices. Additionally, the COVID-19 has dragged many people below the poverty line as they lost their all-available means to earn a living which can be a challenging factor for the growth of ambulatory blood pressure. Further lack of healthcare professionals owing to the pandemic is restraining market growth. Between January 2020 and May 2021, surveillance data reported to WHO showed 3.45 million deaths due to COVID-19. Of these only 6,643 deaths were identified as being in health and care workers (HCWs), but this figure significantly under-reports the burden of mortality worldwide in this group.
Ambulatory Blood Pressure Monitoring Industry Outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Ambulatory Blood Pressure Monitoring Market. Key companies of this market are-
1. BPL Group
3. GE Company
4. Spacelabs Healthcare
5. Welch Allyn Inc
6. Rudolf Riester GmbH
7. Bosch & Sohn GmbH
8. Daifuku Co
9. SunTech Medical
10. Schiller AG
Recent Developments/Product Launches:
- On December 21, 2021, Illinois, United States-based medical technology company “GE Healthcare” announced that it has successfully acquired “BK Medical Holdings.” BK Medical is a US-based company that develops medical devices. Moreover, the transaction was brought to a close by GE Healthcare with a payment of $1.45 billion.
- On December 13, 2021, “Hill-Rom” announced its acquisition by Illinois, United States-based health care company “Baxter International.” Hill-Rom is a medical device company that bought welch Allyn back in 2015. and Parent company of Welch Allyn. Coming back to on merger Baxter made a payment of $10.5 billion where every existing shareholder of Hill-Rom will receive $156 per share.
- On July 8, 2020, Washington, United States-based medical device manufacturer company “Spacelabs Healthcare” announced that it has successfully acquired US-based company “Boxveiw” at an undisclosed price. The acquisition of Boxveiw is supposed to be the best thing sliced bread for the expansion of the digital health portfolio of Spacelabs.
Report Code: HCR 0176
Report Code: HCR 0263
Report Code: HCR 0162
For more Lifesciences and Healthcare Market reports, please click here